MedPath

EFFECTS OF A CULTURE-SPECIFIC BEHAVIOR MODIFICATION PROGRAM ON HBA1C AND BLOOD PRESSURE AMONG DIABETES PERSONS WITH HYPERTENSION COMORBIDITY, NORTHEASTERN THAILAND

Phase 3
Completed
Conditions
Hypertension
Persons with comorbidity of diabetes and hypertension
Behavior modification
IMB model
Blood pressure
Diabetes
The Information-Motivation-Behavioral Skills Model
HbA1c
Registration Number
TCTR20240418004
Lead Sponsor
The 90th Anniversary of Chulalongkorn University Scholarship
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
57
Inclusion Criteria

1. Patients who have a clinical diagnosis of type 2 diabetes mellitus with hypertension
comorbidity
2. HbA1c values greater than 7 %
3. Systolic Blood pressure levels greater than 140 or diastolic blood pressure greater than 90 mmHg in the past six months
4. They are aged 40 to 59 years, both male and female
5. An inactive lifestyle (engage in less than 150 minutes per week of physical exercise by self-report)
6. Body Mass Index less than 30 kg per m2
7. Patients who have been prescribed at least one blood pressure medication (the nurses will verify medications)
8. Patients who have provided a signed informed consent form
9. Patients who have agreed to participate in the study for the full 12-week duration
10. Possession of a mobile phone able to receive data or messages.

Exclusion Criteria

1. Blood pressure indicating the need for medication
2. Cardiovascular disease history of ischemic heart disease
3. Significant dementia or psychosis
4. Conditions limiting the ability to reduce blood pressure
5. The participants of intervention groups who did not exercise or record in the mobile application

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c baseline and three months HbA1c will be analyzed using A1c machine
Secondary Outcome Measures
NameTimeMethod
Blood pressure Baseline and every month Blood pressure will be measured using a digital sphygmomanometer with patients seated after 5 minutes of rest and two BP reading at 2 minutes intervals.
© Copyright 2025. All Rights Reserved by MedPath